Pricing Log in Create free account

MacroGenics, Inc. (MGNX) vs NervGen Pharma Corp. (NGEN)

MacroGenics, Inc. and NervGen Pharma Corp. are both Biotechnology companies. MacroGenics, Inc. and NervGen Pharma Corp. are of similar size ($148.4M and $143.1M). NervGen Pharma Corp. has the higher net margin (0.00% vs −8.70%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, MacroGenics, Inc. leads on 6 and NervGen Pharma Corp. on 5.

Valuation

Metric MGNX NGEN Biotechnology median
P/E n/m n/m 10.60
P/S 0.88 n/m 9.40
P/B 3.46 3.63 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.61 n/m 0.66
EV/Sales (0.11) n/m 9.02
Earnings yield (9.44%) (17.89%) (32.88%)
Free cash flow yield (44.23%) (14.96%) (23.13%)

Profitability

Metric MGNX NGEN Biotechnology median
Gross margin 85.23% — 68.51%
Operating margin (20.45%) 0.00% 0.00%
Net margin (8.70%) 0.00% 0.00%
Free cash flow margin (39.08%) 0.00% 0.00%
Return on equity (32.61%) (94.85%) (51.96%)
Return on assets (4.94%) (40.66%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric MGNX NGEN Biotechnology median
Revenue growth (TTM) 1.32% — 6.76%
EPS growth (last fiscal year) (10.28%) (68.14%) 29.88%
Revenue growth, 5-year CAGR 7.35% — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric MGNX NGEN Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.96 2.07 4.97
Net debt to EBITDA 2.82 0.95 1.01

Dividend

Metric MGNX NGEN Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric MGNX NGEN Biotechnology median
Market cap 148.42m 143.13m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack